TSE:IMV IMV (IMV) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free IMV Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$1.12▼C$1.1252-Week Range N/AVolume15,761 shsAverage Volume56,822 shsMarket CapitalizationC$13.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsHeadlinesStock AnalysisAnalyst ForecastsHeadlines Get IMV alerts: Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About IMV Stock (TSE:IMV)IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.Read More Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide IMV Stock News HeadlinesApril 17, 2024 | finance.yahoo.comMaveropepimut-S (MVP-S, previously known as DPX-Survivac) Drug Research Report 2024: 7 Major Markets Size, Forecasts, and Emerging Insights 2019-2032April 13, 2024 | msn.com‘Golden Bachelor’ pair announces divorce after three months of marriageApril 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 12, 2024 | msn.comToyota Mini Fortuner News: Price, launch date, engine, specifications — All that we know about Hyundai Creta, Kia Seltos, Tata Harrier and Mahindra Scorpio-N rivalApril 5, 2024 | msn.comDisease Severity Similar for RSV as Unvaccinated COVID-19, InfluenzaApril 4, 2024 | msn.com12 Cheap College Meals People Still Love Long After GraduationMarch 22, 2024 | finance.yahoo.comBIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENTMarch 13, 2024 | msn.comFJ Cruiser 2.0? Toyota Planning New Rugged SUV for Late 2024April 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.March 12, 2024 | msn.com11 Signs Eggs Are Not Safe To EatMarch 11, 2024 | msn.comToyota said to be working on new SUV based on Hilux Champ, to slot below FortunerMarch 8, 2024 | msn.comToyota to introduce Mini-Fortuner to compete with Mahindra Scorpio N: Check features, expected launch timelineMarch 6, 2024 | msn.comToyota mini-Fortuner global debut this year, likely to be called FJMarch 6, 2024 | finance.yahoo.comBioVaxys Technology Corp. Granted Voluntary Management Cease Trade OrderFebruary 23, 2024 | msn.comAge of Mythology: Retold's developers are going 'way beyond' the definitive editions for Age of Empires: 'We want to build the game in your head'February 3, 2024 | msn.comAsian Cup 2023: Quarter-final fixtures, results, schedule, group tables and how to watch in UKFebruary 2, 2024 | msn.comThird-Gen Toyota Fortuner Transforms into a Rugged Off-Road SUV. Possible 4Runner Variant?February 2, 2024 | msn.comThird-Gen Toyota Fortuner Morphs Into a Boxy Off-Road SUV. It Could Double as a 4Runner?January 31, 2024 | tmcnet.comiHit Tech Wowed the TPE24 Expo as Top1 Choice for Intense Flavor and Silky VaporDecember 20, 2023 | msn.comHow Toyota Was Able to Make Its $13,000 Future Pickup So AffordableNovember 13, 2023 | msn.comToyota's $10,000 Pickup Of The Future Is Utilitarian PerfectionNovember 6, 2023 | news.yahoo.comToyota’s $10,000 Future Pickup Truck Is Basic Transportation PerfectionOctober 31, 2023 | msn.comToyota’s Future-Ready Pickup Truck: IMV 0 Wows Dads at 2023 Japan Mobility ShowOctober 27, 2023 | msn.comToyota IMV 0 Concept: Everything We Know So FarOctober 25, 2023 | msn.comToyota FT-3e Concept Gives a Glimpse of the Next-Generation bZ4XOctober 25, 2023 | msn.com2023 Tokyo motor show: latest news and picturesOctober 24, 2023 | msn.com$52M in Tax-Exempt Bond Financing Approved For NY Blood Center HQSee More Headlines Receive IMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:IMV CUSIPN/A CIKN/A Webwww.imvaccine.com Phone+1-902-4921819FaxN/AEmployees63Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($6.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-37,990,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-508.58% Return on Assets-61.78% Debt Debt-to-Equity Ratio1,231.01 Current Ratio2.93 Quick Ratio2.32 Sales & Book Value Annual SalesC$23,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.61 Book ValueC($0.69) per share Price / BookN/AMiscellaneous Outstanding Shares11,710,000Free FloatN/AMarket CapC$13.12 million OptionableNot Optionable Beta1.52 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Andrew Hall M.Sc.CEO & DirectorMs. Brittany Davison C.A. (Age 33)CPA, Chief Accounting Officer, Corp. Sec. & Director Comp: $207.9kDr. Jeremy R. Graff Ph.D. (Age 53)Chief Scientific Officer Comp: $558.1kDelphine DavanSr. Director of Communications & Investor RelationsMr. Stephan Fiset M.B.A.M.Sc., VP of Clinical ResearchKey CompetitorsAeterna ZentarisTSE:AEZSResverlogixTSE:RVXSirona BiochemCVE:SBMAntibe TherapeuticsTSE:ATENeptune Wellness SolutionsTSE:NEPTView All Competitors IMV Stock Analysis - Frequently Asked Questions Should I buy or sell IMV stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMV in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" IMV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMV, but not buy additional shares or sell existing shares. View IMV analyst ratings or view top-rated stocks. When did IMV's stock split? Shares of IMV reverse split before market open on Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of IMV own? Based on aggregate information from My MarketBeat watchlists, some companies that other IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN), Aphria (APHA), Enbridge (ENB), Sorrento Therapeutics (SRNE), Medical Facilities (DR) and ReNeuron Group (RENE). How do I buy shares of IMV? Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:IMV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMV Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
